PALX Palomino Laboratories Inc.
Semiconductors & Related Devices · OTC · SEC CIK 1938569 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-219.5%
TTM EPS YoY108.9%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-60.1%
ROA-55.5%
ROIC (approx.)-7,675.4%
Asset turnover—
Leverage & solvency
Liabilities / assets5.9%
Debt / equity0.00x
Current ratio18.90x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.61x
Accruals ratio-21.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | — | — | — | — | — |
| R&D expense | $1.80M | $668,636 | $438,240 | — | — | — | — | — |
| SG&A expense | $2.62M | $696,635 | $805,363 | $742,639 | $1.60M | $337,445 | $17,828 | $4,005 |
| Operating income | -$4.42M | -$1.37M | -$1.24M | -$742,639 | -$1.60M | -$337,445 | -$17,828 | -$137,962 |
| Interest expense | — | — | — | — | — | $8,227 | $8,137 | — |
| Income tax | -$1,000 | — | — | — | — | — | — | — |
| Net income | -$4.42M | -$1.36M | -$1.24M | -$742,607 | -$1.82M | $388,000 | -$985,000 | -$9,963 |
| EBITDA | -$4.40M | -$1.35M | -$1.24M | — | — | — | — | — |
| EPS (basic) | -0.19 | -0.06 | -0.07 | — | -0.54 | 0.15 | -0.44 | — |
| EPS (diluted) | -0.19 | -0.06 | -0.07 | — | -0.54 | 0.15 | -0.44 | — |
| Weighted avg. shares (diluted) | 22.82M | 21.82M | 18.51M | — | 3.38M | 2.58M | 2.23M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $17.79M | $19.44M | $6.66M | $8.12M | $7.90M | $1.72M | $137,729 | $135,000 |
| Current assets | $17.90M | $19.59M | $6.83M | $8.43M | — | $1,887 | $18,220 | $138,125 |
| PP&E, net | $1.38M | $1.24M | $315,573 | — | — | — | — | — |
| Goodwill | $26,000 | — | — | — | — | — | — | — |
| Intangibles | $21,000 | — | — | — | — | — | — | — |
| Total assets | $19.70M | $21.04M | $7.36M | $8.43M | $8.31M | $1,887 | $18,220 | $138,125 |
| Current liabilities | $947,000 | $368,885 | $228,862 | $337,000 | $999,013 | $364,431 | $336,989 | $6,431 |
| Total liabilities | $1.17M | $475,962 | $351,970 | $337,000 | $999,013 | $364,431 | $336,989 | $156,431 |
| Shareholders' equity | $18.53M | $20.57M | $7.01M | $8.10M | $7.32M | -$447,000 | -$990,000 | -$17,000 |
| Shares outstanding | 27.64M | 23.16M | 18.92M | 18.77M | 17.61M | 5.00M | 5.00M | 4.50M |
| Cash flow statement | ||||||||
| Operating cash flow | -$1.57M | -$1.12M | -$1.12M | -$894,156 | -$309,969 | -$84,083 | $3,052 | -$5,700 |
| Capital expenditure | $128,348 | $941,316 | $318,336 | — | — | — | — | — |
| Free cash flow | -$1.70M | -$2.06M | -$1.43M | — | — | — | — | — |
| Investing cash flow | -$58,348 | -$941,316 | -$318,336 | — | — | — | — | — |
| Financing cash flow | -$24,975 | $14.85M | -$30,000 | $1.12M | $6.48M | $19,980 | $20 | $144,753 |
| Depreciation & amortization | $17,000 | $12,450 | $2,763 | — | — | — | — | — |
| Stock-based compensation | $2.35M | $100,528 | — | $18,406 | $1.26M | $155,000 | — | — |
Free plan shows the latest 8 periods; Pro shows all 17 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.